Volume 24; Issue supp-S2

Main
Clinical Therapeutics
Volume 24; Issue supp-S2

Clinical Therapeutics

Volume 24; Issue supp-S2

1

Assessing the clinical significance of quality-of-life measures in oncology research: State of the science: Overview

Jeff A Sloan, David Cella, Marlene Frost, Gordon H Guyatt, Mirjam Sprangers, Tara Symonds

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 288 KB

english, 2002

2

Methods for explaining the clinical significance of health status measures

GordonH. Guyatt, David Osoba, AlbertW. Wu, KathleenW. Wyrwich, GeoffreyR. Norman

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 70 KB

english, 2002

3

Group versus individual approaches to understanding the clinical significance of differences or changes in quality of life

David Cella, Monika Bullinger, Charles Scott, Ivan Barofsky

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 74 KB

english, 2002

4

Assessing the clinical significance of single items relative to summated scores

JeffA. Sloan, NeilK. Aaronson, JosephC. Cappelleri, DianeL. Fairclough, Claudette Varricchio

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 155 KB

english, 2002

5

Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores

MarleneH. Frost, AmyE. Bonomi, CarolEstwing Ferrans, GilbertY. Wong, RonD. Hays

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 154 KB

english, 2002

6

Assessing meaningful change over time in quality of life: A user's guide for clinicians

MirjamA.G. Sprangers, CarolM. Moinpour, TimothyJ. Moynihan, DonaldL. Patrick, DennisA. Revicki

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 73 KB

english, 2002

7

The clinical significance of QOL results: Practical considerations for specific audiences

Tara Symonds, Rick Berzon, Patrick Marquis, Teresa Rummans

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 149 KB

english, 2002

8

Quality-of-life measures as leading indicators of adverse clinical events after bone marrow and stem cell transplantation

NigelE. Bush, GaryW. Donaldson, CarolM. Moinpour

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 254 KB

english, 2002

9

Improving the quality of life for patients with cancer through the cancer supportive care program and web site

ErnestH. Rosenbaum, David Spiegel, Holly Gautier, Margaret Hawn, Pat Fobair, Bernadette Festa, Kathleen Dzubur, Francine Manuel, Arnold Tayam, Jane Verdurmen Peart, Jeanne Fournier, Pat Kramer, Bita N

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 164 KB

english, 2002

10

Clinical benefit in patients with cancer of the pancreas: How does it compare with clinically significant changes in quality-of-life scores?

Andrea Bezjak, Janet Dancey, Dongsheng Tu, JosephL. Pater, Lesley Seymour, Malcolm Moore

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 263 KB

english, 2002

11

Measurement of fatigue: Determining minimally important clinical differences

AnnaL. Schwartz, P.M. Meek, LillianM. Nail, Melissa Donofrio, Marylin Grainger, Terry Throckmorton, Magdelena Mateo

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 243 KB

english, 2002

12

What is the relationship between clinical and health-related quality-of-life measures?

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 136 KB

english, 2002

13

Interpretation of change and longitudinal validity of the quality of life for respiratory illness questionnaire in inpatient pulmonary rehabilitation

HenkF. van Stel, RianneA. Maillé, VivianT. Colland, Walter Everaerd

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 137 KB

english, 2002

14

Using patient- and clinician-rated anchors to evaluate change on the functional assessment of cancer therapy—biologic response modifiers

ElizabethA. Hahn, Ari Gnanasakthy, G.Alastair Glendenning, MarkV. Sorensen, Linda Odom, David Cella

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 147 KB

english, 2002

15

The cancer outcomes measurement working group: Evaluating the state of the science and developing recommendations for improving outcomes assessment in cancer

Claire Snyder, CarolynCook Gotay, Joseph Lipscomb

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 75 KB

english, 2002

16

Minimal important difference: Can we predict its magnitude?

JolieG. Ringash, Andrea Bezjak, DonaldA. Redelmeier, Brian O'Sullivan

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 165 KB

english, 2002

17

Assessment of palliation in patients with lung cancer: Comparisons between patient symptom diary scores and “minimum clinical change” in quality-of-life scores

MichaelD. Brundage, JosephL. Pater, Dongsheng Tu, Michael Palmer, Andrea Bezjak, Peter Dixon

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 162 KB

english, 2002

18

Confirmatory factor analysis and clinical significance of the illness intrusiveness ratings scale in men and women with common cancer diagnoses

GeraldM. Devins, Andrea Bezjak, Kenneth Mah, AndrewD. Loblaw

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 174 KB

english, 2002

19

Correlations between target scores and anchor ratings on a health transition questionnaire

David Osoba, Andrea Bezjak, Benny Zee, Marlo Whitehead, JosephL. Pater

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 180 KB

english, 2002

20

Long-term quality of life associated with a chemotherapy-based regimen for newly diagnosed central nervous system germ cell tumors: The first international cooperative trial

StephenA. Sands, Stewart Kellie, Howard Weiner, Amy Davidow, Cathy Pietanza, Blanca Diez, Judith Villablanca, Casilda Balmaceda, Jonathan Finlay

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 82 KB

english, 2002

21

Quality-of-life and behavioral follow-up study of pediatric craniopharyngioma survivors

StephenA. Sands, Jessica Milner, Carol Maxfield, Jeffrey Wisoff

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 75 KB

english, 2002

22

Clinical significance of quality of life: The patient advocate perspective

Cynthia Chauhan, Judy Perotti, Wayland Eppard

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 75 KB

english, 2002

23

Measuring the quality of life of patients with breast cancer treated with breast-conserving techniques

MariaM. Hardy, Anita Axiak, Grace Boyea, Christine Flynn, Linda Lewis, Michelle Wallace

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 152 KB

english, 2002

24

A randomized assessment of three quality-of-life questionnaires for patients with prostate cancer undergoing different radiation treatments

KimberlyK. Senter, Christine Mitchell, MariaM. Hardy, Christine Flynn, Michelle Wallace, Linda Lewis, Grace Boyea, Carol St. Henry, Jennifer Divo

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 255 KB

english, 2002

25

Response shift in individualized quality of life in patients with advanced prostate cancer

JonathanE. Rees, Dympna Waldron, CiaranA. O'Boyle, RuaraidhP. MacDonagh

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 165 KB

english, 2002

26

A rasch analysis of the functional scales of the European Organization for Research and Treatment of Cancer QLQ-C30 and the implications for clinical significance

AdamB. Smith, GalinaI. Velikova, PeterJ. Selby

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 164 KB

english, 2002

27

Use of individual quality-of-life data in oncology consultations: Approach to interpretation of individual results and physicians' feedback on clinical usefulness

GalinaI. Velikova, JuliaM. Brown, AdamB. Smith, PeterJ. Selby

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 180 KB

english, 2002

28

Clarifying the significance of treatment effects on quality-of-life dimensions using structural equation modeling: Example from peripheral arterial obstructive diseases

Patrick Marquis, Linda Abetz

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 73 KB

english, 2002

29

Clinical significance of changes in quality-of-life scores during neoadjuvant treatment of esophageal cancer

JaneM. Blazeby, Jo Nicklin, SteveJ. Falk, C.Paul Barham, Jon Vickers, Derek Alderson

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 174 KB

english, 2002

30

Interpretation of quality-of-life data from a clinician's point of view: Getting to the clinical part of clinically meaningful change

CherylR. Dennison, NancyK. Leidy, Cheryl Silberman, Anne Heyes

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 165 KB

english, 2002

31

Meaningful change in cancer-specific quality-of-life scores: Differences between improvement and worsening

Kelly Dineen, David Cella, ElizabethA. Hahn, Susan Yount

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 170 KB

english, 2002

32

Quality of life of cancer patients as reported in a tumor registry follow-up

MarcellineR. Harris, Marlene Frost, KatherineA. Clement-Brown, PaulJ. Novotny, JeffA. Sloan, Christopher Chute

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 170 KB

english, 2002

33

What is measured by the schedule for the evaluation of individual quality of life-direct weighting?

Annette Vielhaber, Peter Homel, Ellen Gold, Steven Malamud, RonaldH. Blum, RussellK. Portenoy, AliceB. Kornblith

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 167 KB

english, 2002

34

Quality-of-life changes during the first cycle of myelosuppressive chemotherapy

BarryV. Fortner, Brad Stolshek, Heith Durrence, DanielJ. Taylor, TheodoreA. Okon, Lee Schwartzberg, K. Tauer, ArthurC. Houts

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 168 KB

english, 2002

35

A phase II trial and quality-of-life analysis of a 5-day regimen of oral 5-fluorouracil bracketed by a 7-day regimen of oral eniluracil in untreated patients with unresectable or metastatic colorectal carcinoma

TimothyJ. Hobday, MichelleR. Mahoney, DanielJ. Sargent, JeffA. Sloan, Richard Goldberg

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 163 KB

english, 2002

36

Use of event charts for summarizing clinically significant changes in oncology quality-of-life data

PamelaJ. Atherton, Britta Jasperson, Andrea Nibbe, KatherineA. Clement-Brown, Christine Allmer, PaulJ. Novotny, Charles Erlichman, JeffA. Sloan

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 99 KB

english, 2002

37

What does it all mean? Using health-related quality-of-life data to interpret treatment outcomes

NancyK. Leidy, Deborah Jonas, Cheryl Silberman, MaryKay Margolis, Anne Heyes

Journal:

Clinical Therapeutics

Year:

2002

Language:

english

File:

PDF, 165 KB

english, 2002

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски